Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2004, Vol. 103, No. 4, pp. 1183.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gahmberg, C. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gahmberg, C. G.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

Cell adhesion: a partner for many

Cell adhesion is of vital importance for a number of cellular functions. Several molecular families of cell adhesion proteins are known, among which the most important are the integrins and their cellular and soluble ligands. Currently, 24 different integrins have been described. They are complex heterodimeric molecules and need activation to become adhesive. They are commonly grouped in subfamilies according to their {beta} chains.


Blood cells express at least members of the {beta}1, {beta}2, {beta}3, and {beta}7 integrin families, but none are found on mature red cells. The primary cellular ligands for the leukocyte-specific {beta}2 integrins are the intercellular adhesion molecules (ICAM); 5 have been described. Platelets are known to adhere through the {alpha}IIb{beta}3 integrin to fibrinogen. Among the ICAMs, ICAM-4 is unique due to its expression on erythroid cells. This molecule was originally described as a member of the LandsteinerWiener (LW) blood group of antigens, but subsequent cloning and adhesion assays showed that it is a member of the ICAM family of adhesion proteins.1 Its physiologic function has remained unknown, but it shows an interesting relationship to the Rh antigens.2 Thus, Rhnull cells lack the ICAM-4 molecule and they may be part of a large membrane protein complex. Whereas the other ICAMs specifically bind to {beta}2 integrins, ICAM-4 has recently been found to interact with several types of integrins expressed on blood and endothelial cells.

In this issue, Mankelow and colleagues (page 1503) have used mutational analysis to map the binding site on ICAM-4 for {alpha}V integrins and visualized the binding site using a structural model based on the structure of ICAM-2. Interestingly, the binding site is located in the first immunoglobulin (Ig) domain adjacent to but partially separated from those previously described for {alpha}L{beta}2 and {alpha}M{beta}2. The binding site for {alpha}L{beta}2 is also confined to the first Ig domain of ICAM-4, whereas the binding site for {alpha}M{beta}2 also involves domain 2.3 A relatively large binding site also seems to be the case for ICAM-4 binding to the platelet integrin {alpha}IIb{beta}3.4 The {alpha}4{beta}1 integrin is known to bind to leucine–aspartic acid–valine (LDV) sequences and the binding site on ICAM-4 is evidently different from those of the other integrins. Based on the mutational studies, Mankelow et al synthesized peptides that inhibited the ICAM-4/{alpha}V-integrin interaction. The active peptides are clearly different from those previously described to interfere with ICAM/{beta}2, {alpha}4{beta}1,5 and {alpha}IIb{beta}3 interactions. The findings that red cells may specifically bind through ICAM-4 to integrins expressed on all major types of blood and endothelial cells indicate that it may be possible to develop reagents specific for the different ICAM-4 (red cell)/integrin interactions. Because of the pivotal role of red cells in human physiology and disease such reagents would be of great value.

--- Carl G. Gahmberg
University of Helsinki

References

  1. Bailly P, Tontti E, Hermand P, et al. The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol. 1995;25: 3316-3320.[Medline] [Order article via Infotrieve]

  2. Gahmberg CG. Molecular characterization of the human red cell Rho(D) antigen. EMBO J. 1983;2: 223-227.[Medline] [Order article via Infotrieve]

  3. Hermand P, Huet M, Callebaut I, et al. Binding sites of leukocyte {beta}2 integrins (LFA-1, Mac-1) on the human ICAM-4/LW blood group protein. J Biol Chem. 2000;275: 26002-26010.[Abstract/Free Full Text]

  4. Hermand P, Gane P, Huet M, et al. Red cell ICAM-4 is a novel ligand for platelet-activated {alpha}IIb{beta}3 integrin. J Biol Chem. 2003;278: 4892-4898.[Abstract/Free Full Text]

  5. Spring FA, Parsons SF, Ortlepp S, et al. Intercellular adhesion molecule-4 binds {alpha}4{beta}1 and {alpha}v-family integrins through novel integrin-binding mechanisms. Blood. 2001;98: 458-466.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Identification of critical amino-acid residues on the erythroid intercellular adhesion molecule-4 (ICAM-4) mediating adhesion to {alpha}V integrins
Tosti J. Mankelow, Frances A. Spring, Stephen F. Parsons, R. Leo Brady, Narla Mohandas, Joel A. Chasis, and David J. Anstee
Blood 2004 103: 1503-1508. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
E. Ihanus, L. M. Uotila, A. Toivanen, M. Varis, and C. G. Gahmberg
Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4
Blood, January 15, 2007; 109(2): 802 - 810.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gahmberg, C. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gahmberg, C. G.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020